Articles dans des revues avec comité de lecture (45)
  1. 25. Rombout, A., Stamatopoulos, B., Lagneaux, L., Lust, S., Offner, F., Naessens, E., Vanderstraeten, H., Verhasselt, B., & Amans, J. P. (2015). Lipoprotein lipase SNPs rs13702 and rs301 correlate with clinical outcome in chronic lymphocytic leukemia patients. PloS one, 10(3), e0121526. doi:10.1371/journal.pone.0121526
  2. 26. Crompot, E., Van Damme, M., Duvillier, H., Pieters, K., Vermeesch, M., Perez-Morga, D., Meuleman, N., Mineur, P., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2015). Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control. PloS one, 10(5), e0127209. doi:10.1371/journal.pone.0127209
  3. 27. Van Damme, M., Crompot, E., Meuleman, N., Mineur, P., Dessars, B., El Housni, H., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2014). Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients. Epigenetics, 9(10), 1374-1381. doi:10.4161/15592294.2014.969628
  4. 28. Philippart, P., Meuleman, N., Stamatopoulos, B., Najar, M., Pieters, K., De Bruyn, C., Bron, D., & Lagneaux, L. (2013). In Vivo Production of Mesenchymal Stromal Cells After Injection of Autologous Platelet-Rich Plasma Activated by Recombinant Human Soluble Tissue Factor in the Bone Marrow of Healthy Volunteers. Tissue Engineering. Part A. Tissue Engineering. doi:10.1089/ten.TEA.2013.0244
  5. 29. Andre, T., Meuleman, N., Stamatopoulos, B., De Bruyn, C., Pieters, K., Bron, D., & Lagneaux, L. (2013). Evidences of Early Senescence in Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells. PloS one, 8(3), e59756. doi:10.1371/journal.pone.0059756
  6. 30. Van Damme, M., Crompot, E., Meuleman, N., Mineur, P., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2012). HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance. Epigenetics, 7(12), 1403-1412. doi:10.4161/epi.22674
  7. 31. Stamatopoulos, B., Meuleman, N., De Bruyn, C., Pieters, K., Mineur, P., Le Roy, C., Saint-Georges, S., Varin-Blank, N., Cymbalista, F., Bron, D., & Lagneaux, L. (2012). AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments. Haematologica, 97(4), 608-615. doi:10.3324/haematol.2011.052779
  8. 32. Raicevic, G., Najar, M., Stamatopoulos, B., De Bruyn, C., Meuleman, N., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2011). The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. Cellular immunology, 270(2), 207-216. doi:10.1016/j.cellimm.2011.05.010
  9. 33. De Bruyn, C., Najar, M., Raicevic, G., Meuleman, N., Pieters, K., Stamatopoulos, B., Delforge, A., Bron, D., & Lagneaux, L. (2011). A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem cells and development, 20(3), 547-557. doi:10.1089/scd.2010.0260
  10. 34. De Bruyn, C., Najar, M., Raicevic, G., Meuleman, N., Pieters, K., Stamatopoulos, B., Delforge, A., Bron, D., & Lagneaux, L. (2011). A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from wharton's jelly without enzymatic treatment. Stem cells and development, 20(3), 547-557. doi:10.1089/scd.2010.0260
  11. 35. Najar, M., Raicevic, G., Id Boufker, H., Stamatopoulos, B., De Bruyn, C., Meuleman, N., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2010). Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. Experimental hematology, 38(10), 922-932. doi:10.1016/j.exphem.2010.05.007
  12. 36. Stamatopoulos, B., Meuleman, N., De Bruyn, C., Delforge, A., Bron, D., & Lagneaux, L. (2010). The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces apoptosis, downregulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells. Haematologica, 95(7), 1136-1143. doi:10.3324/haematol.2009.013847
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>